90380 Rsv monoc antb seasn .5ml intramuscular
Also known as: RSV mAb seasonal, palivizumab 0.5ml, RSV seasonal prophylaxis
Respiratory syncytial virus monoclonal antibody for seasonal prophylaxis administered intramuscularly in 0.5 milliliter dose.
In Plain Language
RSV prevention shot; seasonal infant lung protection
Clinical Context
Monthly intramuscular monoclonal antibody injection during respiratory syncytial virus season for high-risk pediatric populations to prevent disease.
RVU Information
CPT 90380 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Medicine category, 34% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 90380?
CPT 90380 (Rsv monoc antb seasn .5ml intramuscular) is a Medicine code. Respiratory syncytial virus monoclonal antibody for seasonal prophylaxis administered intramuscularly in 0.5 milliliter dose.
Who uses CPT code 90380?
CPT 90380 is used by Pediatrics, Infectious Disease, Pulmonology. Monthly intramuscular monoclonal antibody injection during respiratory syncytial virus season for high-risk pediatric populations to prevent disease.
When is CPT 90380 used?
Monthly intramuscular monoclonal antibody injection during respiratory syncytial virus season for high-risk pediatric populations to prevent disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.